A crosstalk between macroangiopathy and microangiopathy in type 2 diabetes

Int J Cardiol. 2013 Sep 20;168(1):550-1. doi: 10.1016/j.ijcard.2013.01.199. Epub 2013 Mar 1.

Authors

Hidetaka Hamasaki¹, Sumie Moriyama, Hidekatsu Yanai

Affiliation

¹ Department of Internal Medicine, National Center for Global Health and Medicine Kohnodai Hospital, Chiba, Japan.

PMID: 23453875
DOI: 10.1016/j.ijcard.2013.01.199

No abstract available

Keywords: Atherosclerosis; Erythropoietin; Microangiopathy; Type 2 diabetes; Vascular endothelial growth factor.

Publication types

Case Reports
Letter
Research Support, Non-U.S. Gov't

MeSH terms

Aged
Diabetes Mellitus, Type 2 / blood*
Diabetes Mellitus, Type 2 / diagnostic imaging*
Diabetic Angiopathies / blood*
Diabetic Angiopathies / diagnostic imaging*
Erythropoietin / blood
Female
Humans
Microvessels / diagnostic imaging*
Microvessels / metabolism
Radiography
Vascular Endothelial Growth Factor A / blood

Substances

EPO protein, human
VEGFA protein, human
Vascular Endothelial Growth Factor A
Erythropoietin